ArticlePharmacogenetics and genomics2015

Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with body composition changes in women on aromatase inhibitors for ER (+) breast cancer.

Nicola Napoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.